Aarti Industries Ltd.

NSE: AARTIIND | BSE: 524208 | ISIN: INE769A01020 | Industry: Specialty Chemicals
| Mid-range Performer
383.3500 -3.20 (-0.83%)
NSE Sep 24, 2025 15:53 PM
Volume: 408.6K
 

383.35
-0.83%
Reliance Securities
Revenue from pharma business grew by 3% YoY. Notably, the segment recorded its highest therapies i.e. antihypertensive, cardiovascular, oncology and corticosteroids etc. The company also has a strong pipeline of approvals and visibility to maintain growth momentum. Segmental EBIT grew by 20% YoY in 3QFY20, and we expect similar growth in 4QFY20E as well. Specialty Chemical Biz Slight Decline in Margin...
Aarti Industries Ltd.'s price crossed below 30Day SMA today
More from Aarti Industries Ltd.
Recommended